16
replacement therapy. However, the kidney has endogenous repair mechanisms that are 17 activated in response to injury. A better understanding of the molecular mechanisms of 18 repair, and how we might use them therapeutically to retain or restore kidney function
19
following an insult could greatly improve patient outcomes. Accordingly, this has been 20 the subject of both basic research and clinical trials.
21
A variety of animal models of chronic kidney injury have been developed, including 22 subtotal nephrectomy, diabetic or obstructive nephropathy, and ischemia-reperfusion.
23
Studies using these models, as well as in vitro assays have provided insight into the 24 complex cascade of events that follows kidney injury including inflammation, apoptosis, 25 proliferation, epithelial-mesenchymal transition (EMT), fibrosis, and regeneration (1).
26
Hepatocyte Growth Factor (HGF) and Transforming Growth Factor-β (TGF-β) are 27 induced with kidney injury and act as major regulators of these events.
28
Studies initially supported a generally reparative role for HGF and a damaging, 
41
Receptor, TβRII, and in vitro using proximal tubule cells derived from these mice.
42
However, instead of finding increased HGF signaling in cells lacking TβRII, they saw the 
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